Navigation Links
Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call
Date:7/1/2008

ion of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

ABOUT IBIS T5000 BIOSENSOR SYSTEM AND IBIS BIOSCIENCES, INC.

Ibis Biosciences, Inc., a majority-owned subsidiary of Isis Pharmaceuticals, has developed and is commercializing the Ibis T5000(TM) Biosensor System for rapid identification and characterization of infectious agents. The Ibis T5000 is currently intended for research use only and not for use in diagnostic procedures. It is capable of identifying virtually all bacteria, viruses and fungi, and can provide information about drug resistance, virulence and strain type of these pathogens. Commercial applications for the Ibis T5000 Biosensor System include epidemiologic surveillance, monitoring of pandemic diseases, identification of emerging or previously unknown pathogens, forensic characterization of human samples, identification of sources of hospital-associated infections, and, in the future, human infectious disease diagnostics. Ibis develops, manufactures and markets Ibis T5000 instruments and assay kits. Additional information about Ibis can be found by selecting the Ibis link from Isis' homepage at http://www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results
2. deCODE genetics to Webcast Presentations at Annual R&D Event
3. deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference
4. Exelixis Announces June 25 Webcast of Presentation at the Piper Jaffray Europe Conference
5. Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
6. Schering-Plough Schedules Conference Call and Webcast for 2008 Second Quarter Earnings
7. Gen-Probe to Webcast Presentation at the William Blair & Company 28th Annual Growth Stock Conference
8. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
9. Gen-Probe to Webcast Presentation at Seventh Annual Needham Biotechnology and Medical Technology Conference
10. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
11. Exelixis Announces June 5 Webcast of Conference Call Regarding Its $150 Million Funding Commitment from Deerfield Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... PA (PRWEB) January 15, 2014 The Pittcon ... publisher of Food Safety Tech , an e-Journal and ... signed an agreement for the second year for the co-location ... Pittcon 2014. The partnership provides that the registration fee to ...
(Date:1/15/2014)... Look inside the new Preferred Solutions® catalog ... from fluid handling to instruments to supplies. Many items ... order. , Preferred Solutions features a full selection ... model for precise flow control and dispensing to I/P® ...
(Date:1/15/2014)... JOSE, California , January 15, 2014 ... cancer, today announced the appointment of Thomas C Reynolds MD, ... 20 years, development experience gained in the biotechnology industry, most ... "I am delighted to welcome Tom at this transformative time ...
(Date:1/15/2014)... This webinar will focus on EMA and FDA ... biosimilars. , Regulatory frameworks are evolving many countries to ... complex nature of biopharmaceuticals makes the demonstration of biosimilarity ... Based on the specific aspects of biosimilar drug development ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2
... BSP Biological Signal Processing Ltd. (BSP) (TASE: ... accurate diagnosis of Coronary Artery Disease (CAD), recently announced ... evaluating the performance of the company,s HyperQ technology in ... results was accepted for publication in the prestigious ...
... 2011 Cell Therapeutics, Inc. (the "Company") (NASDAQ and ... Meeting of Shareholders (the "Annual Meeting") held on Friday, November ... elected James A. Bianco, M.D., Vartan Gregorian, Ph.D., and ... s Board of Directors until the Company, s 2014 ...
... 2011 Callibra, Inc. dba Discharge 1-2-3 of ... ten winners of the 2011 Chicago Innovation Awards for their ... an event held at Chicago,s Harris Theater on Tuesday, November ... Awards, celebrating its 10th year, is the Chicago region,s foremost ...
Cached Biology Technology:Positive Clinical Study Results for BSP's HyperQ Technology 2Positive Clinical Study Results for BSP's HyperQ Technology 3Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders 2Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award 2Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award 3
(Date:4/24/2014)... the Scientific Reports journal. , CSIC researcher Carles ... of CSIC and Pompeu Fabra University-UPF), explains: "When the Y ... that it did not match with the DNA recovered from ... genome and to make a functional interpretation in order to ... , The functional genome analysis was based on two ...
(Date:4/24/2014)... could now be treated in three days, rather than two ... Cryptococcus a form of yeast - infections ... They are found in many parts of the world, ... people with weakened immune systems. This infection kills up to ... tested the effects of the most commonly used drug on ...
(Date:4/24/2014)... With a new generation of military veterans returning home ... become a prominent concern in American medical institutions and ... 35 percent of personnel deployed to Iraq and Afghanistan ... South Carolina School of Medicine is shedding light on ... and surprising ways. , The rise in PTSD has ...
Breaking Biology News(10 mins):The blood preserved in the pumpkin did not belong to Louis XVI 2Treatment for deadly yeast disease reduced to 3 days 2New study links inflammation in those with PTSD to changes in microRNA 2New study links inflammation in those with PTSD to changes in microRNA 3
... peat moss Sphagnum palustre appears to be a ... researchers have discovered. The study is published in New ... plant of the Hawaiian population appears to have been produced ... back to a single parent. Surprisingly, the genetic diversity ...
... California, Riverside scientists released a natural enemy of the ... control the spread of the psyllid, an invasive pest that ... trees in home landscapes. This is the first time the ... Riverside Executive Vice Chancellor Dallas Rabenstein and ...
... 15th anniversary of the return of wolves to Yellowstone National ... health is emerging, scientists conclude in a new report. ... young aspen and willow trees has diminished as elk populations ... increased. Trees and shrubs have begun recovering along some streams, ...
Cached Biology News:UC Riverside scientists release natural enemy of Asian citrus psyllid 2UC Riverside scientists release natural enemy of Asian citrus psyllid 3UC Riverside scientists release natural enemy of Asian citrus psyllid 4An ecosystem being transformed - Yellowstone 15 years after the return of wolves 2An ecosystem being transformed - Yellowstone 15 years after the return of wolves 3
...
...
Cell Lysis Buffer is used to lyse cells under nondenaturing conditions....
Rad 50 Immunogen: c-terminal mRad 50 (604 amino acids). Storage: 4 C...
Biology Products: